Interleukin 7 worsens graft-versus-host disease.

Abstract:

:Impaired immune reconstitution has moved to the forefront of clinical problems limiting progress in allogeneic bone marrow transplantation (BMT). The identification of therapies that can enhance immune reconstitution by increasing thymopoiesis is critical to solving this problem. Interleukin 7 (IL-7) is the most potent thymopoietic cytokine identified thus far. To study the effects of IL-7 on immune reconstitution and graft-versus-host disease (GVHD) following allogeneic BMT, we administered recombinant human IL-7 (rhIL-7) in a murine parent into an F1 model. Results showed that rhIL-7 therapy lowered the "threshold" T-cell dose required to induce both clinical signs of GVHD as well as lethal GVHD. Histologic analysis of GVHD target tissues revealed that rhIL-7 increased the degree of inflammation and tissue damage observed at all T-cell doses studied, but did not change the pattern of organs affected or the histologic appearance of the GVHD within target organs. In addition, we evaluated the capacity for rhIL-7 to enhance thymopoiesis in the setting of allogeneic T cell-depleted (TCD) and T-cell-replete BMT. We observed that rhIL-7 therapy enhanced thymic function in TCD allogeneic BM transplant recipients, but not in animals that received even modest doses of T cells presumably due to thymic toxicity of the graft-versus-host reaction. Thus, caution must be exercised as IL-7 is developed clinically as an immunorestorative agent for use in the setting of allogeneic BMT. These results suggest that use of IL-7 should be limited to the setting of TCD BMT to obtain the greatest benefit on immune competence with the least toxicity.

journal_name

Blood

journal_title

Blood

authors

Sinha ML,Fry TJ,Fowler DH,Miller G,Mackall CL

doi

10.1182/blood-2002-04-1082

subject

Has Abstract

pub_date

2002-10-01 00:00:00

pages

2642-9

issue

7

eissn

0006-4971

issn

1528-0020

journal_volume

100

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Anomalous function of vimentin in chronic lymphocytic leukemia lymphocytes.

    abstract::Chronic lymphocytic leukemia (CLL) lymphocytes manifest anomalous motility and cap formation. Since these processes involve cytoskeletal proteins, vimentin from intermediate filaments of normal and CLL lymphocytes was investigated using hetero- and monoclonal antisera. The antisera reacted predominantly with a 60-kD p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Stark RS,Liebes LF,Shelanski ML,Silber R

    更新日期:1984-02-01 00:00:00

  • Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells.

    abstract::Sickle cell disease (SCD) is characterized by a single point mutation in the seventh codon of the β-globin gene. Site-specific correction of the sickle mutation in hematopoietic stem cells would allow for permanent production of normal red blood cells. Using zinc-finger nucleases (ZFNs) designed to flank the sickle mu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-12-615948

    authors: Hoban MD,Cost GJ,Mendel MC,Romero Z,Kaufman ML,Joglekar AV,Ho M,Lumaquin D,Gray D,Lill GR,Cooper AR,Urbinati F,Senadheera S,Zhu A,Liu PQ,Paschon DE,Zhang L,Rebar EJ,Wilber A,Wang X,Gregory PD,Holmes MC,Reik A

    更新日期:2015-04-23 00:00:00

  • Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials.

    abstract::One hundred seventy-nine patients with acute nonlymphoblastic leukemia in first remission (n = 75), chronic myelocytic leukemia in chronic or accelerated phase (n = 48) or leukemia in advanced stage (n = 56) were given HLA-identical marrow grafts and randomized to receive methotrexate or cyclosporine for prevention of...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Storb R,Deeg HJ,Fisher L,Appelbaum F,Buckner CD,Bensinger W,Clift R,Doney K,Irle C,McGuffin R

    更新日期:1988-02-01 00:00:00

  • Increased peripheral platelet destruction and caspase-3-independent programmed cell death of bone marrow megakaryocytes in myelodysplastic patients.

    abstract::To investigate underlying mechanisms of thrombocytopenia in myelodysplastic syndrome (MDS), radiolabeled platelet studies were performed in 30 MDS patients with platelet counts less than 100 x 10(9)/L. Furthermore, plasma thrombopoietin and glycocalicin index (a parameter of platelet or megakaryocyte destruction) were...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-06-2108

    authors: Houwerzijl EJ,Blom NR,van der Want JJ,Louwes H,Esselink MT,Smit JW,Vellenga E,de Wolf JT

    更新日期:2005-05-01 00:00:00

  • Growth and development following marrow transplantation for leukemia.

    abstract::One hundred forty-two patients between the ages of 1 and 17 years who survived disease-free more than 1 year after marrow transplantation for hematologic malignancy had growth and development evaluations from one to 14 years posttransplant (median 4 years). Prior to transplant all children received multiagent chemothe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sanders JE,Pritchard S,Mahoney P,Amos D,Buckner CD,Witherspoon RP,Deeg HJ,Doney KC,Sullivan KM,Appelbaum FR

    更新日期:1986-11-01 00:00:00

  • Identification of human and mouse hematopoietic stem cell populations expressing high levels of mRNA encoding retrovirus receptors.

    abstract::One obstacle to retrovirus-mediated gene therapy for human hematopoietic disorders is the low efficiency of gene transfer into pluripotent hematopoietic stem cells (HSC). We have previously shown a direct correlation between retrovirus receptor mRNA levels in mouse HSC and the efficiency with which they are transduced...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Orlic D,Girard LJ,Anderson SM,Pyle LC,Yoder MC,Broxmeyer HE,Bodine DM

    更新日期:1998-05-01 00:00:00

  • Pattern of pyruvate kinase isozymes in erythroleukemia cell lines and in normal human erythroblasts.

    abstract::To further investigate the erythroid nature of the two human erythroleukemia cell lines, K562 and HEL-60, and to define the ontogeny of pyruvate kinase (PK) isozymes (R, M2) in developing human erythroid cells, we have studied the isozymic alterations, if any, during differentiation of these cell lines in vitro and no...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Max-Audit I,Testa U,Kechemir D,Titeux M,Vainchenker W,Rosa R

    更新日期:1984-10-01 00:00:00

  • Detection of clonotypic IGH and TCR rearrangements in the neonatal blood spots of infants and children with B-cell precursor acute lymphoblastic leukemia.

    abstract::An attractive hypothesis is that in utero exposure of hematopoietic cells to oncogenic agents can induce molecular changes leading to overt acute lymphoblastic leukemia (ALL) in infants and perhaps older children as well. Although supported by studies of identical infant twins with concordant leukemia, and of nontwine...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yagi T,Hibi S,Tabata Y,Kuriyama K,Teramura T,Hashida T,Shimizu Y,Takimoto T,Todo S,Sawada T,Imashuku S

    更新日期:2000-07-01 00:00:00

  • Molecular basis of glutathione reductase deficiency in human blood cells.

    abstract::Hereditary glutathione reductase (GR) deficiency was found in only 2 cases when testing more than 15 000 blood samples. We have investigated the blood cells of 2 patients (1a and 1b) in a previously described family suffering from favism and cataract and of a novel patient (2) presenting with severe neonatal jaundice....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-08-042531

    authors: Kamerbeek NM,van Zwieten R,de Boer M,Morren G,Vuil H,Bannink N,Lincke C,Dolman KM,Becker K,Schirmer RH,Gromer S,Roos D

    更新日期:2007-04-15 00:00:00

  • Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase.

    abstract::In patients with chronic myeloid leukemia, BCR-ABL mutations contribute to resistance to tyrosine kinase inhibitor therapy. We examined the occurrence of treatment-emergent mutations and their impact on response in patients from the ENESTnd phase 3 trial. At the 3-year data cutoff, mutations were detected in approxima...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2012-04-423418

    authors: Hochhaus A,Saglio G,Larson RA,Kim DW,Etienne G,Rosti G,De Souza C,Kurokawa M,Kalaycio ME,Hoenekopp A,Fan X,Shou Y,Kantarjian HM,Hughes TP

    更新日期:2013-05-02 00:00:00

  • Human acute stem cell leukemia with multilineage differentiation potential via cascade activation of growth factor receptors.

    abstract::The morphologic, immunophenotypic, genotypic, genomic, and functional features of an undifferentiated acute leukemia with stem cell features are reported. At light and electron microscopy, the leukemic population was represented by primitive progenitor cells with no evidence of differentiation. The blasts were CD34(+)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.12.4634

    authors: Testa U,Torelli GF,Riccioni R,Muta AO,Militi S,Annino L,Mariani G,Guarini A,Chiaretti S,Ritz J,Mandelli F,Peschle C,Foa R

    更新日期:2002-06-15 00:00:00

  • L-arginine availability regulates T-lymphocyte cell-cycle progression.

    abstract::L-arginine (L-Arg) plays a central role in several biologic systems including the regulation of T-cell function. L-Arg depletion by myeloid-derived suppressor cells producing arginase I is seen in patients with cancer inducing T-cell anergy. We studied how L-Arg starvation could regulate T-cell-cycle progression. Stim...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-06-031856

    authors: Rodriguez PC,Quiceno DG,Ochoa AC

    更新日期:2007-02-15 00:00:00

  • Control of regulatory T cells is necessary for vaccine-like effects of antiviral immunotherapy by monoclonal antibodies.

    abstract::Regulatory T cells (Tregs) down-regulate immunity and are associated with chronic viral infections, suggesting that their inhibition might be used to treat life-threatening diseases. Using the FrCasE mouse retroviral model, we have recently shown that short mAb-based immunotherapies can induce life-long protective imm...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-06-432153

    authors: Nasser R,Pelegrin M,Plays M,Gros L,Piechaczyk M

    更新日期:2013-02-14 00:00:00

  • Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants.

    abstract::Male recipients of transplants from female (F-->M) hematopoietic stem cell donors represent a special group in whom donor T cells that are specific for recipient minor histocompatibility antigens encoded by Y-chromosome genes may contribute to a graft-versus-leukemia (GVL) effect and to graft-versus-host disease (GVHD...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2603

    authors: Randolph SS,Gooley TA,Warren EH,Appelbaum FR,Riddell SR

    更新日期:2004-01-01 00:00:00

  • Vascular endothelial cells and granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF.

    abstract::Cultured mononuclear phagocytes produce soluble factors that stimulate endothelial cells to release GM-colony-stimulating activity (GM-CSA). One such factor was recently identified as interleukin 1 (IL 1). Studies were designed to determine which types of granulopoietic factors are released by IL 1-stimulated endothel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zsebo KM,Yuschenkoff VN,Schiffer S,Chang D,McCall E,Dinarello CA,Brown MA,Altrock B,Bagby GC Jr

    更新日期:1988-01-01 00:00:00

  • Enhancement of the biologic effects of interleukin-3 in vivo by anti-interleukin-3 antibodies.

    abstract::Interleukin-3 (IL-3) has been shown to be a promising agent in the stimulation of bone marrow regeneration following myeloablative therapy. The biologic half-life of this agent is very short (5 to 15 minutes), which limits the effectiveness of low-dose therapy. Here we show that the biologic effects of low-dose IL-3 i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jones AT,Ziltener HJ

    更新日期:1993-08-15 00:00:00

  • Immunologic characterization of a granulocytic leukemia of inbred strain 13 guinea pigs: presence of Ia-positive myeloblasts.

    abstract::Membrane markers expressed by a transplantable granulocytic leukemia induced in inbred strain 13 guinea pigs by N-nitroso-N-butylurea have been investigated by serologic and immunochemical methods. Although the leukemic myeloblasts have no detectable surface immunoglobulin or Fc receptors, they have been found to synt...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Clement LT,Hu C,Shevach EM,Green I

    更新日期:1980-02-01 00:00:00

  • Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reaction.

    abstract::We sequentially studied bone marrow (BM) samples of 25 patients in complete remission of an acute lymphoblastic leukemia (ALL) using a simplified polymerase chain reaction (PCR) strategy (direct use of the PCR product as a clonogenic probe recognizing rearranged Ig heavy chain sequences) as a first approach. BM aspira...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nizet Y,Van Daele S,Lewalle P,Vaerman JL,Philippe M,Vermylen C,Cornu G,Ferrant A,Michaux JL,Martiat P

    更新日期:1993-09-01 00:00:00

  • One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation.

    abstract::No consensus exists on whether acyclovir prophylaxis should be given for varicella-zoster virus (VZV) prophylaxis after hematopoietic cell transplantation because of the concern of "rebound" VZV disease after discontinuation of prophylaxis. To determine whether rebound VZV disease is an important clinical problem and ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2007-03-077644

    authors: Erard V,Guthrie KA,Varley C,Heugel J,Wald A,Flowers ME,Corey L,Boeckh M

    更新日期:2007-10-15 00:00:00

  • Persistent macrocytosis assessed by erythrocyte subpopulation analysis following erythrocyte regeneration in cats.

    abstract::Serial erythrocyte volume distribution curves were used to characterize changes in erythrocyte subpopulations following the induction of Heinz body hemolytic anemia in cats. Macrocytes produced in response to hemolysis were observed after loss of reticulum. After recovery from hemolysis, a gradual reduction in mean ce...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Weiser MG,Kociba GJ

    更新日期:1982-08-01 00:00:00

  • Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.

    abstract::Intrachromosomal amplification of chromosome 21 (iAMP21) defines a distinct subgroup of childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL) that has a dismal outcome when treated with standard therapy. For improved diagnosis and risk stratification, the initiating genetic events need to be elucidated. To...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-01-329961

    authors: Rand V,Parker H,Russell LJ,Schwab C,Ensor H,Irving J,Jones L,Masic D,Minto L,Morrison H,Ryan S,Robinson H,Sinclair P,Moorman AV,Strefford JC,Harrison CJ

    更新日期:2011-06-23 00:00:00

  • Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL.

    abstract::This phase 2 study evaluated whether substituting bortezomib for vincristine in frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) therapy could improve efficacy in non-germinal center B-cell-like diffuse large B-cell lymphoma (non-GCB DLBCL), centrally confirmed by immunohist...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2015-03-632430

    authors: Offner F,Samoilova O,Osmanov E,Eom HS,Topp MS,Raposo J,Pavlov V,Ricci D,Chaturvedi S,Zhu E,van de Velde H,Enny C,Rizo A,Ferhanoglu B

    更新日期:2015-10-15 00:00:00

  • Inhibition of NF-kappaB by a TAT-NEMO-binding domain peptide accelerates constitutive apoptosis and abrogates LPS-delayed neutrophil apoptosis.

    abstract::Delivery of biologically active peptides into human polymorphonuclear neutrophils (PMNs) has implications for studying cellular functions and may be therapeutically relevant. The transcription factor nuclear factor-kappaB (NF-kappaB) regulates the expression of multiple genes controlling inflammation, proliferation, a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-09-2960

    authors: Choi M,Rolle S,Wellner M,Cardoso MC,Scheidereit C,Luft FC,Kettritz R

    更新日期:2003-09-15 00:00:00

  • One-day ex vivo culture allows effective gene transfer into human nonobese diabetic/severe combined immune-deficient repopulating cells using high-titer vesicular stomatitis virus G protein pseudotyped retrovirus.

    abstract::Retrovirus-mediated gene transfer into long-lived human pluripotent hematopoietic stem cells (HSCs) is a widely sought but elusive goal. A major problem is the quiescent nature of most HSCs, with the perceived requirement for ex vivo prestimulation in cytokines to induce stem cell cycling and allow stable gene integra...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rebel VI,Tanaka M,Lee JS,Hartnett S,Pulsipher M,Nathan DG,Mulligan RC,Sieff CA

    更新日期:1999-04-01 00:00:00

  • Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V.

    abstract::The proteolytic cleavage and subsequent inactivation of recombinant human factor VIII (rhFVIII) and human factor VIIIa (rhFVIIIa) by recombinant human activated protein C (rAPC) was analyzed in the presence and absence of human protein S and human factor V (FV). Membrane-bound rhFVIIIa spontaneously looses most of its...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lu D,Kalafatis M,Mann KG,Long GL

    更新日期:1996-06-01 00:00:00

  • Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens.

    abstract::Peripheral blood mononuclear cells (PBMC) from 17 patients receiving HLA-identical sibling bone marrow grafts were stimulated with host pretransplant PBMC. Cytotoxic T-cell lines (TCL) with specificity for host pretransplant PBMC were obtained from 9 of these patients, all presenting with severe graft-versus-host dise...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Niederwieser D,Grassegger A,Auböck J,Herold M,Nachbaur D,Rosenmayr A,Gächter A,Nussbaumer W,Gaggl S,Ritter M

    更新日期:1993-04-15 00:00:00

  • Adhesive properties of the carbohydrate-modified von Willebrand factor (CHO-vWF).

    abstract::In this cooperative study, we explored the role of the carbohydrate moiety (CHO) of von Willebrand factor (vWF) in supporting platelet adhesion. Because of previous discrepant results, all purification steps and CHO modifications by various enzymes were critically evaluated. Under our conditions, CHO-modified vWF prep...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Federici AB,De Romeuf C,De Groot PG,Samor B,Lombardi R,D'Alessio P,Mazurier C,Mannucci PM,Sixma JJ

    更新日期:1988-04-01 00:00:00

  • Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.

    abstract::Diverse human cancers with poor prognosis, including many lymphoid and myeloid malignancies, exhibit high levels of Mcl-1. To explore the impact of Mcl-1 overexpression on the hematopoietic compartment, we have generated vavP-Mcl-1 transgenic mice. Their lymphoid and myeloid cells displayed increased resistance to a v...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-281071

    authors: Campbell KJ,Bath ML,Turner ML,Vandenberg CJ,Bouillet P,Metcalf D,Scott CL,Cory S

    更新日期:2010-10-28 00:00:00

  • Quantitative trait locus on chromosome 8q influences the switch from fetal to adult hemoglobin.

    abstract::The switch from fetal to adult hemoglobin is incomplete; the residual fetal hemoglobin in adults is restricted to a subset of erythrocytes called F cells. F-cell levels are influenced by a sequence variant (C-->T) at position -158 upstream of the gamma-globin gene, termed the XmnI-Ggamma polymorphism. How the Ggamma-1...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-02-0527

    authors: Garner C,Silver N,Best S,Menzel S,Martin C,Spector TD,Thein SL

    更新日期:2004-10-01 00:00:00

  • Inactivation of purified human alpha 2-antiplasmin and purified human C1 inhibitor by synthetic fibrinolytic agents.

    abstract::3-Hydroxypropyl flufenamide (Flu-HPA) is one of a series of flufenamic acid derivatives that enhances blood clot lysis in vitro. Studies of possible mechanisms of action of Flu-HPA were undertaken. The profibrinolytic activity of Flu-HPA in clot lysis assays was found to be dependent on plasminogen. The influence of F...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miles LA,Burnier JP,Verlander MS,Goodman M,Kleiss AJ,Griffin JH

    更新日期:1981-06-01 00:00:00